Muscle volume loss a prognostic factor for death in liver cirrhosis patients and special relationship to portal hypertension

Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis

(2017) Atsushi Hiraoka et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Efficacy and tolerability of an IFN-free regimen with DCV/ASV for elderly patients infected with HCV genotype 1B

(2017) Hidenori Toyoda et al.   JOURNAL OF HEPATOLOGY

Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older

(2017) F. Conti et al.   JOURNAL OF VIRAL HEPATITIS

Sarcopenia and two types of presarcopenia in Japanese patients with chronic liver disease

(2016) Atsushi Hiraoka et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib

(2016) Atsushi Hiraoka et al.   HEPATOLOGY RESEARCH

Sarcopenia is a poor prognostic factor following hepatic resection in patients aged 70 years and older with hepatocellular carcinoma

(2016) Norifumi Harimoto et al.   HEPATOLOGY RESEARCH

Effects of in-hospital exercise on liver function, physical ability, and muscle mass during treatment of hepatoma in patients with chronic liver disease

(2016) Shunji Koya et al.   HEPATOLOGY RESEARCH

Sarcopenia, but not visceral fat amount, is a risk factor of postoperative complications after major hepatectomy

(2015) Takaaki Higashi et al.   International Journal of Clinical Oncology

Muscle atrophy as pre-sarcopenia in Japanese patients with chronic liver disease: computed tomography is useful for evaluation

(2015) Atsushi Hiraoka et al.   JOURNAL OF GASTROENTEROLOGY

Preoperative intramuscular adipose tissue content is a novel prognostic predictor after hepatectomy for hepatocellular carcinoma

(2015) Yuhei Hamaguchi et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia

(2014) Liang-Kung Chen et al.   Journal of the American Medical Directors Association

Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation

(2014) Yuhei Hamaguchi et al.   LIVER TRANSPLANTATION

Long-term entecavir therapy results in falls in serum hepatitis B surface antigen levels and seroclearance in nucleos(t)ide-naïve chronic hepatitis B patients

(2013) T. Hara et al.   JOURNAL OF VIRAL HEPATITIS

Sarcopenia is a prognostic factor in living donor liver transplantation

(2013) Toshiro Masuda et al.   LIVER TRANSPLANTATION

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

(2012) Tetsuya Hosaka et al.   HEPATOLOGY

New contrast enhanced ultrasonography agent: Impact of Sonazoid on radiofrequency ablation

(2011) Atsushi Hiraoka et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging

(2011) Katsuhiro Sano et al.   RADIOLOGY

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People

(2010) A. J. Cruz-Jentoft et al.   AGE AND AGEING

Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan

(2007) Masatoshi Makuuchi et al.   HEPATOLOGY RESEARCH